Content about Varicella zoster virus

December 21, 2012

The Food and Drug Administration has approved a new drug for reducing the severity of chickenpox symptoms, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for reducing the severity of chickenpox symptoms, the agency said Friday.

The FDA announced the approval of Cangene Corp.'s Varizig (varicella zoster immune globulin [human]) for varicella zoster, the virus that causes chickenpox. The FDA said Varizig was the only FDA-approved immune globulin for the virus after exposure.

March 29, 2011

A decision by the Food and Drug Administration to lower the age at which patients can receive a vaccine for shingles opens the door for pharmacists to administer it to more patients.

CAMP HILL, Pa. — A decision by the Food and Drug Administration to lower the age at which patients can receive a vaccine for shingles opens the door for pharmacists to administer it to more patients.

Rite Aid said Tuesday that pharmacists at more than 2,100 of its stores now could vaccinate patients ages 50 years and older with Merck’s Zostavax (zoster vaccine live) thanks to the FDA’s approval of the vaccination for patients in that age group. Previously, it was only approved for patients ages 60 years and older.

March 25, 2011

The Food and Drug Administration has approved a vaccine for shingles in older patients.

SILVER SPRING, Md. — The Food and Drug Administration has approved a vaccine for shingles in older patients.

The agency said Thursday that it had approved Merck’s Zostavax (zoster vaccine live) vaccine in patients ages 50 to 59 years. The vaccine already is approved for those ages 60 years and older.

Shingles, caused by the varicella-zoster virus, the same virus that causes chickenpox, affects about 200,000 people in the United States ages 50 to 59 years each year.

January 12, 2010

Rite Aid on Wednesday announced the launch of a national shingles vaccination and education campaign...